(Q37566190)

21 August 2017

1 reference

title

The forum for collaborative HIV research: a model for an integrated and inclusive approach to clinical research and drug development (English)

1 reference

21 August 2017

1 reference

research collaboration

1 reference

V Miller

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

29 July 2009

1 reference

Clinical Pharmacology & Therapeutics

21 August 2017

published in

1 reference

21 August 2017

volume

86

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

332-335

1 reference

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

Drug development strategies for salvage therapy: conflicts and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

A new approach for 'deep salvage' trials in advanced HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

HIV clinical trial design for antiretroviral development: moving forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

Biology of CCR5 and its role in HIV infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

Monitoring of long-term toxicities of HIV treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

The FDA as a public health agency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiretroviral therapies for treatment-experienced patients: current status and research challenges

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.140

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.140

1 reference

21 August 2017

1 reference